Development of Immune-Chromatographic Monoclonal Test-System for the Detection of <i>Yersinia pseudotuberculosis</i>, Serogroup I

Development of Immune-Chromatographic Monoclonal Test-System for the Detection of <i>Yersinia pseudotuberculosis</i>, Serogroup I

Objective of the study was to develop monoclonal immunoassay for the detection of the pseudotuberculosis agent, serogroup I. Materials and methods. Specific components, that were used for immune-chromatographic test-system development were mouse monoclonal antibodies of hybrid cell lines, obtained t...

Full description

Bibliographic Details
Main Authors:	N. V. Bogacheva, G. D. Elagin, D. V. Pechenkin, A. A. Kytmanov, O. V. Tikhvinskaya, A. V. Eremkin
Format:	Article
Language:	Russian
Published:	Federal Government Health Institution, Russian Research Anti-Plague Institute “Microbe” 2016-06-01
Series:	Проблемы особо опасных инфекций
Subjects:	возбудитель псевдотуберкулеза серогруппы i моноклональные антитела иммунохроматографическая тест-система pseudotuberculosis agent, serogroup i monoclonal antibodies, immune-chromatographic test-system
Online Access:	https://journal.microbe.ru/jour/article/view/308

Similar Items

Immuno-Chromatographic Test System Application for Rapid Detection of <I>Francisella tularensis</I> Lipopolysaccharide in Monitoring of Natural Foci
by: A. A. Zaitsev, et al.
Published: (2013-03-01)

Manufacturing of Hybridomas-Producers of Monoclonal Anti-Bodies to Tularemia Agent Antigens
by: O. O. Fomenkov, et al.
Published: (2015-06-01)

INDEL-Typing of <i>Yersinia pseudotuberculosis</i> Strains
by: A. L. Trukhachev, et al.
Published: (2023-02-01)

EFFECT OF YERSINIA PSEUDOTUBERCULOSIS TOXINS ON THE BIOFILM FORMATION
by: N. A. Terenteva, et al.
Published: (2017-12-01)

Systemic characteristic of safety profile of monoclonal antibodies used in rheumatology practice
by: A. V. Philippova, et al.
Published: (2019-10-01)

Physicochemical and antigenic properties of the urea-extracted surface structures of <i>Yersinia pseudotuberculosis</i> O:1b
by: Anna V. Kryukova, et al.
Published: (2022-11-01)

RADIOIMMUNOTHERAPY IN THE TREATMENT OF MALIGNANCIES
by: V. I. Chernov, et al.
Published: (2016-07-01)

Biomolecular characteristics of Yersinia pseudotuberculosis and Yersinia enterocolitica isolated in Siberia and in the Far East
by: T. V. Karimova, et al.
Published: (2016-05-01)

Yersinia pseudotuberculosis-derived adhesins
by: A. A. Byvalov, et al.
Published: (2019-11-01)

<i>Yersinia pseudotuberculosis </i>Typing Using Multi-Locus Variable-Number Tandem Repeat Analysis
by: V. V. Evseeva, et al.
Published: (2015-12-01)

CHARACTERISTICS OF FORMATION, INHIBITION AND DESTRUCTION OF YERSINIA PSEUDOTUBERCULOSIS BIOFILMS FORMING ON ABIOTIC SURFACES
by: N. A Terentieva, et al.
Published: (2015-06-01)

NEW MONOCLONAL ANTIBODY FOR TUMOR-ASSOCIATED PROTEIN PMEPA1 DETECTION
by: V. V. Volkomorov, et al.
Published: (2016-02-01)

Biofilm Formation in <i>Yersinia pestis</i> Strains of the Main and Non-Main Subspecies and <i>Yersinia pseudotuberculosis</i> on the Model of <i>Caernorabditis elegans</i>
by: N. A. Vidyaeva, et al.
Published: (2009-02-01)

BIOLOGICAL ACTIVITY OF YERSINIA PSEUDOTUBERCULOSIS TOXINS
by: N. A. Terentieva, et al.
Published: (2016-12-01)

Producing and prospects for the use of bispecific antibodies for the treatment of cancer
by: S. E. Sedykh, et al.
Published: (2019-01-01)

Lipopolysaccharide of the <i>Yersinia pseudotuberculosis</i> Complex
by: Yuriy A. Knirel, et al.
Published: (2021-09-01)

“CAMEL” ANTIBODIES: FEATURES OF THEIR STRUCTURE, PREPARATION AND APPLICATION
by: Alexey Alekseevich Andreev, et al.
Published: (2020-06-01)

Electron-Microscopic Investigation of Interactions between <I>Yersinia pseudotuberculosis</I>, <I>Yersinia pestis</I> Cells and Specific Bacteriophages
by: A. V. Chernyad’Ev, et al.
Published: (2014-12-01)

Impact of MgtC on the Fitness of <i>Yersinia pseudotuberculosis</i>
by: Peng Li, et al.
Published: (2023-12-01)

Safety issues of monoclonal antibodies used in rheumatology
by: A. V. Philippova, et al.
Published: (2020-01-01)

Biological and Physical-Chemical Properties of <i>Yersinia pseudotuberculosis</i> Cultures in the Process of Submerged Cultivation at Various Temperatures
by: K. E. Gavrilov, et al.
Published: (2010-04-01)

Monoclonal antibodies against Mycobacterium tuberculosis, detecting the antigen in urine of the pulmonary tuberculosis patients
by: A. V. Onyan, et al.
Published: (2016-02-01)

Comparative Characteristics of Antioxidative Enzymes of <i>Yersinia pestis</i> Strains of Different Subspecies and <i>Yersinia pseudotuberculosis</i> Strains
by: N. A. Vidyaeva, et al.
Published: (2008-04-01)

Diversity of CRISPR loci in <i>Yersinia pseudotuberculosis</i> strains and their association with pathogenicity factors
by: Nadezhda P. Peretolchina, et al.
Published: (2023-07-01)

New Monoclonal Antibodies for the Diagnosis of Influenza and other Acute Respiratory Viral Infections
by: A. A. Sominina, et al.
Published: (2015-10-01)

Experimental and clinical approaches to a radioimmunotherapy in o
by: E. V. Abakushina, et al.
Published: (2016-02-01)

The Course of Generalized Meningococcal Infection Caused by Meningococcus Serogroup W135
by: M. V. Ivanova, et al.
Published: (2016-11-01)

Pathomorphology of experimental infection caused by dormant <i>Yersinia pseudotuberculosis</i> strains
by: L. M. Somova, et al.
Published: (2021-12-01)

In silico comparative analysis of crispr-cas system structures of Yersinia pseudotuberculosis causing different clinical manifestations of pseudotuberculosis
by: N. P. Peretolchina, et al.
Published: (2019-05-01)

Immunochemical activity of <i>Yersinia pseudotuberculosis</i> ompF and ompC porins evaluated by optical trapping
by: Ilya V. Konyshev, et al.
Published: (2022-12-01)

Diagnosis of Bactec samples by immunoglobulins of mouse hyperimmune sera obtained against modified antigens of the cell wall of Mycobacterium tuberculosis
by: I. V. Kozlova, et al.
Published: (2019-11-01)

Focal segmental glomerulosclerosis: current status of the problem
by: I. T. Murkamilov, et al.
Published: (2020-01-01)

Preparations of next generation monoclonal antibodies (issues and prospects)
by: Zh. I. Avdeeva, et al.
Published: (2018-02-01)

Rational sequence of monoclonal antibodies in the treatment of non-resectable head and neck squamous cell carcinoma
by: L. V. Bolotina, et al.
Published: (2022-04-01)

Prevalence and Characteristics of Yersinia Enterocolitica and Yersinia Pseudotuberculosis from Raw Milk Supplied in Tehran
by: Sara Sharifi Yazdi, et al.
Published: (2023-02-01)

The production of hyperimmune pseudotuberculosis sera
by: T. Yu. Zagoskina, et al.
Published: (2021-08-01)

Far Eastern Scarlet-Like Fever is a Special Clinical and Epidemic Manifestation of <i>Yersinia pseudotuberculosis</i> Infection in Russia
by: Larisa M. Somova, et al.
Published: (2020-06-01)

Yersinia pseudotuberculosis Septicemia and HIV
by: Maria Grazia Paglia, et al.
Published: (2005-07-01)

COMPARATIVE ANALYSIS OF CRISPR-CAS SYSTEM STRUCTURES OF YERSINIA PSEUDOTUBERCULOSIS IP32953 AND IP31758
by: N. P. Peretolchina, et al.
Published: (2018-09-01)

Immunogenicity induced by biologicals in the treatment of psoriasis and psoriatic arthritis: View of the problem
by: T. V. Korotaeva
Published: (2016-01-01)